Updates in Low Risk MDS with Dr. Max Stahl

Описание к видео Updates in Low Risk MDS with Dr. Max Stahl

In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept.
Here are the trials we discussed:
1. IWG 2019 response criteria
https://www.ncbi.nlm.nih.gov/pmc/arti...
2. MEDALIST trial: Luspatercept
https://www.nejm.org/doi/10.1056/NEJM...
3. COMMANDS trial : Luspatercept
https://www.thelancet.com/journals/la...
https://www.thelancet.com/journals/la...
4. IMerge trial: Imetelstat
https://www.thelancet.com/journals/la...

Комментарии

Информация по комментариям в разработке